Nika Samadzadeh Tabrizi

Dr. Nika Samadzadeh Tabrizi


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 September 2023 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
NTNika Samadzadeh Tabrizi
Nika Samadzadeh Tabrizi
RDRiley A. Demos
Riley A. Demos
RSRoman Schumann
Roman Schumann
SMSridhar R. Musuku
Sridhar R. Musuku
ASAlexander D. Shapeton
Alexander D. Shapeton

2 July 2024 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
NTNika Samadzadeh Tabrizi
Nika Samadzadeh Tabrizi
GFGregory Fishberger
Gregory Fishberger
SMSridhar R. Musuku
Sridhar R. Musuku
ASAlexander D. Shapeton
Alexander D. Shapeton

1 January 2024 in Journal of Thoracic Disease
Verified
Journal Article
Open access
PDF file
NTNika Samadzadeh Tabrizi
Nika Samadzadeh Tabrizi
EHErin S. Harris
Erin S. Harris
BGBenjamin P. Gallant
Benjamin P. Gallant
TFThomas Fabian
Thomas Fabian
Background: The incidence of synchronous multiple primary lung cancer (SMPLC) is increasing, occurring in up to 20% of lung cancer patients. Accurately identifying SMPLC can be challenging, and failure to recognize SMPLC results in poor outcomes. We sought to assess the staging accuracy of patients with SMPLC at our tertiary institution. Methods: We retrospectively reviewed all patients who were evaluated for lung cancer resection between January 2018 to September 2019. Patients with SMPLC were identified using the modified Martini-Melamed criteria. Preoperative imaging, clinical assessment, and pathologic interpretation were reviewed and compared to the final staging assigned by a multidisciplinary lung cancer tumor board to determine accuracy. Results: Out of 227 patients presenting for lung cancer resection, 47 patients with 119 SMPLC were identified, of which 38 (80.9%) were incorrectly staged by at least one report. Incorrect staging was most common by computed tomography (CT) reports (n=33/47, 70.2%), followed by positron emission tomography-CT (PET-CT) reports (n=28/45, 62.2%), surgeons’ clinical assessment (n=10/47, 21.3%), and histopathology reports (n=8/47, 17.0%). CT reports, when incorrect, under-staged 97.0% (n=32) of patients. PET-CT reports, when incorrect, over-staged 25.0% (n=7) of patients by reporting the second primary nodule to be “consistent with metastasis”. Histopathology reports, when incorrect, over-staged 87.5% (n=7) of patients despite lack of lymph node involvement. Conclusions: Patients with SMPLC are at risk of receiving incorrect treatment based on radiographic and histopathologic staging reports alone. The observed staging inaccuracies are concerning, necessitating increased awareness among physicians caring for lung cancer patients.

29 May 2024 in The American Journal of Surgery
Verified
Journal Article
Closed access
NTNika Samadzadeh Tabrizi
Nika Samadzadeh Tabrizi
MSMichel Pompeu Sá
Michel Pompeu Sá
XJXander Jacquemyn
Xander Jacquemyn
SYSarah Yousef
Sarah Yousef
JBJames A. Brown
James A. Brown
ISIbrahim Sultan
Ibrahim Sultan

9 April 2025 in The American Journal of Surgery
Verified
Journal Article
Closed access
NTNika Samadzadeh Tabrizi
Nika Samadzadeh Tabrizi
NLNicole Lin
Nicole Lin
SPSrinidhi Polkampally
Srinidhi Polkampally
SKSravya Kuchibhotla
Sravya Kuchibhotla
YLYihan Lin
Yihan Lin

7 June 2023 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
NTNika Samadzadeh Tabrizi
Nika Samadzadeh Tabrizi
RRRonnie Ramadan
Ronnie Ramadan
SMSridhar R. Musuku
Sridhar R. Musuku
ASAlexander D. Shapeton
Alexander D. Shapeton